| Alejandra Giselle Borensztein, MD | |
|
900 Haddon Ave # 400-9, Collingswood, NJ 08108-2101 | |
| (856) 559-7616 | |
| (856) 363-4902 |
| Full Name | Alejandra Giselle Borensztein |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 16 Years |
| Location | 900 Haddon Ave # 400-9, Collingswood, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699909556 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocare Llc | 3678562188 | 288 |
News Archive
Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.
The American Psychological Association (APA) lauds the release of the Campaign for Mental Health Reform's action agenda, Emergency Response: A Roadmap for Federal Action on America's Mental Health Crisis, designed to help the federal government transform the delivery of mental health services.
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research celebrated its 35th Annual Awards Gala on Wednesday, October 27th, 2010 at the New York Marriott Marquis and raised a total of $1.45 million.
"Clinically, this finding helps differential diagnosis and reduces the risk of misdiagnosis between two conditions with very different therapeutic options," said Claudio Rapezzi, M.D. from the University of Bologna and S. Orsola-Malpighi Hospital in Bologna, Italy.
› Verified 8 days ago
| Entity Name | Clinical Health Care Associates Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447260435 PECOS PAC ID: 0749180198 Enrollment ID: O20040421001473 |
News Archive
Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.
The American Psychological Association (APA) lauds the release of the Campaign for Mental Health Reform's action agenda, Emergency Response: A Roadmap for Federal Action on America's Mental Health Crisis, designed to help the federal government transform the delivery of mental health services.
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research celebrated its 35th Annual Awards Gala on Wednesday, October 27th, 2010 at the New York Marriott Marquis and raised a total of $1.45 million.
"Clinically, this finding helps differential diagnosis and reduces the risk of misdiagnosis between two conditions with very different therapeutic options," said Claudio Rapezzi, M.D. from the University of Bologna and S. Orsola-Malpighi Hospital in Bologna, Italy.
› Verified 8 days ago
| Entity Name | Advocare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770538696 PECOS PAC ID: 3678562188 Enrollment ID: O20040510001217 |
News Archive
Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.
The American Psychological Association (APA) lauds the release of the Campaign for Mental Health Reform's action agenda, Emergency Response: A Roadmap for Federal Action on America's Mental Health Crisis, designed to help the federal government transform the delivery of mental health services.
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research celebrated its 35th Annual Awards Gala on Wednesday, October 27th, 2010 at the New York Marriott Marquis and raised a total of $1.45 million.
"Clinically, this finding helps differential diagnosis and reduces the risk of misdiagnosis between two conditions with very different therapeutic options," said Claudio Rapezzi, M.D. from the University of Bologna and S. Orsola-Malpighi Hospital in Bologna, Italy.
› Verified 8 days ago
| Entity Name | Endocrinology Consultants, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275721342 PECOS PAC ID: 0840387023 Enrollment ID: O20071105000379 |
News Archive
Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.
The American Psychological Association (APA) lauds the release of the Campaign for Mental Health Reform's action agenda, Emergency Response: A Roadmap for Federal Action on America's Mental Health Crisis, designed to help the federal government transform the delivery of mental health services.
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research celebrated its 35th Annual Awards Gala on Wednesday, October 27th, 2010 at the New York Marriott Marquis and raised a total of $1.45 million.
"Clinically, this finding helps differential diagnosis and reduces the risk of misdiagnosis between two conditions with very different therapeutic options," said Claudio Rapezzi, M.D. from the University of Bologna and S. Orsola-Malpighi Hospital in Bologna, Italy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alejandra Giselle Borensztein, MD 900 Haddon Ave # 400-9, Collingswood, NJ 08108-2101 Ph: (856) 559-7616 | Alejandra Giselle Borensztein, MD 900 Haddon Ave # 400-9, Collingswood, NJ 08108-2101 Ph: (856) 559-7616 |
News Archive
Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.
The American Psychological Association (APA) lauds the release of the Campaign for Mental Health Reform's action agenda, Emergency Response: A Roadmap for Federal Action on America's Mental Health Crisis, designed to help the federal government transform the delivery of mental health services.
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research celebrated its 35th Annual Awards Gala on Wednesday, October 27th, 2010 at the New York Marriott Marquis and raised a total of $1.45 million.
"Clinically, this finding helps differential diagnosis and reduces the risk of misdiagnosis between two conditions with very different therapeutic options," said Claudio Rapezzi, M.D. from the University of Bologna and S. Orsola-Malpighi Hospital in Bologna, Italy.
› Verified 8 days ago
Dr. Marshall Francis Lauer, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 414 Haddon Ave, Collingswood, NJ 08108 Phone: 856-854-7800 Fax: 856-854-1687 | |
Jessica Richmond, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 416 Haddon Ave, Collingswood, NJ 08108 Phone: 856-858-1240 |